Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial of NPC-02 in patients with zinc deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Zinc Deficiency

Drugs mentioned

• NPC-02

Snippet

Sponsor: Nobelpharma | Conditions: Zinc Deficiency | Phase 3 | Status: COMPLETED